openPR Logo
Press release

3D Printed Drugs Market: Research Report Overview by Industry Size, Share, Trends, Growth & Leading Players (2021-2027)

3D Printed Drugs Market 

3D Printed Drugs Market 

Research report presented by UnivDatos, Emphasis on Technology (Inkjet Printing, Fused Deposition Modelling, Stereolithography, Others), Application (Orthopaedic, Neurology, Hearing & Audibility Aid, Medical Implants, Dental, Others), Drug Form (Tablet, Capsules, Multi Drug Implants, Nano Particles, Solutions, Nano Suspension, Encapsulated within a Polymer, Implant), Drugs (Spritam, Others), End-Users (Hospitals, Clinics, Research Laboratories), and Geographical analysis (key regions and countries).

As per the research report, the global 3D Printed Drugs Market is expected to reach the market valuation of US$ 2,064.8 million by 2027 expanding at a reasonable CAGR of 15.2% during the forecast period (2021-2027) from US$ 638.6 million in 2019. The global 3D printed drugs market is witnessing an uptick on account of the government’s investment in the 3D printing technology, raising venture capital for 3D printing startups, and the investment by the pharma companies in 3D printing technology. In a study, it was found that around 63% of the pharma companies are thinking of investing in 3D printing technology and the number of professionals using 3D printing technology was 3 times higher than that of 3 years ago which was in 2017. The Venture capital funding for 3D printing is also one of the most prominent reasons for market growth. Furthermore, the state of Lower Austria and the Austrian federal government together announced two funding packages in 2020 which will support investments in advanced digital technologies, including 3D printing.

For complete research, request for Sample of the report browse through – https://univdatos.com/request_form/form/353

Moreover, the surging prevalence of chronic disease and the rising number of patients globally generating the demand for soluble drugs, due to which the demand for personalized 3D printed medicine is emerging. In a study, it was found that Dysphagia affects approximately 9 million adults per year in the United States and is especially prevalent among the elderly. Characteristically, 50-75% of stroke patients and 60-70% of patients who undergo radiation therapy for head and neck cancer have dysphagia. The government across countries is investing more in healthcare and more emphasis on 3D printing technology for quick production owing to the surging need globally. As per OCED, the government in the United States spend USD 8,032.6 USD per capita in 2015 that increased to USD 9,386.5 USD per capita in 2019 same way in the U.K the government spent 3,043.6 USD per capita in 2015 that increased to USD 3619.5 USD per capita in 2019.

Also, surging government’s emphasis on personalized medicine and the rising end-user’s awareness about the medicine as per individual’s need coupled with the benefits such as high dose in single tablet, swallowable, and different form of drugs is generating the demand for the 3D printed drugs so, the market is promulgating.

For a detailed analysis of the 3D Printed Drugs Market browse through - https://univdatos.com/report/global-3d-printed-drugs-market-current-analysis-and-forecast-2020-2027

The global 3D Printed Drugs market is highly fragmented. The availability of numerous global and local players across regions makes the industry highly competitive. The key players with a considerable market share in the industry are GlaxoSmithKline plc., Aprecia Pharmaceuticals, LLC., AstraZeneca, FabRx Ltd, Merck KGaA, Hewlett Packard Caribe, Cycle Pharmaceuticals, Tvasta, etc. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst technology, inkjet printing segment holds the major share”

Based on product type, the market is fragmented into inkjet printing, fused deposition modeling, stereolithography, and others. The inkjet printing segment dominated the market with a share of 42.2% in 2019 and is expected to maintain its dominance during the forecast period on account of the benefits such as low cost, programmability, high resolution, high throughput, high speed, and biocompatibility of these printers and the launch of new products by the key players in the industry.

“Amongst applications, neurology is expected to dominate the market during the analyzed period”

Based on the applications market is segmented into Orthopedic, Neurology, Hearing & Audibility Aid, Medical Implants, Dental, and others. In 2019, the neurology segment grabbed the major market share and accounted for 35.1% of the market revenue share.  The surging prevalence of the neurological disorder is leading to the growing share of this segment. In a study, it was found that Neurological disorders are the number one cause of disability globally and around 1 billion people throughout the world are affected by some type of neurological disease. Moreover, the orthopedic segment is expected to grow with a CAGR of more than 15.9% during the forecast period of 2021-27.

For a detailed analysis of the components in the 3D Printed Drugs Market browse through - https://univdatos.com/report/global-3d-printed-drugs-market-current-analysis-and-forecast-2020-2027

“Amongst drug form, the tablet is expected to dominate the market during the analyzed period”

Based on the drug form, the market is segmented into the tablet, capsules, multidrug implants, nanoparticles, solutions, nanosuspension, encapsulated within a polymer, and others. In 2019, the tablet segment grabbed the major market share and accounted for 29.8% of the market revenue share.  The properties of tablets such as longer shelf life, variety of forms. Also, it accommodates a higher dose of an active ingredient than a capsule. Moreover, the capsule segment is expected to grow with a CAGR of more than 15.8% during the forecast period of 2021-27.

“North America represents one of the largest markets of the 3D Printed Drugs market”

For a better understanding of the market dynamics of the 3D Printed Drugs market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of APAC) and Rest of the World has been conducted. North America dominated the market and generated revenue of US$ 306.8 million in 2019 owing to the escalating healthcare IT investment in the countries such as the U.S and Canada. Moreover, the presence of well-established players in additive manufacturing makes the region dominant across the globe.

Customization Options:

The 3D Printed Drugs Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Contact us:
UnivDatos Market Insights (UMI)
Email: sales@univdatos.com
Web: https://univdatos.com
Ph: +91 7838604911

About Us:
UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 3D Printed Drugs Market: Research Report Overview by Industry Size, Share, Trends, Growth & Leading Players (2021-2027) here

News-ID: 2289446 • Views: 326

More Releases from UnivDatos Market Insights (UMI)

Healthcare Consulting Services Market Size, Share, Growth 2021-2027 | Cognizant, …
A comprehensive overview of the healthcare consulting services market is recently added by UnivDatos Market Insights to its humongous database. The healthcare consulting services market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Healthcare Consulting Services market. The healthcare consulting services market report offers a
Greenhouse Film Market Size, Share, Growth, Trend 2021-2027 | Key Players Are Gi …
A comprehensive overview of the global Greenhouse Film market is recently added by UnivDatos Market Insights to its humongous database. The report has been aggregated by collecting informative data from various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Greenhouse Film market globally. This report offers a detailed analysis of the latest industry developments and
Active Pharmaceutical Ingredient Market - Comprehensive Insights by Demand Statu …
Global active pharmaceutical ingredient market is expected to witness a CAGR of around 6% during the forecast period. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some drugs have multiple active pharmaceutical ingredients. The rising prevalence of the various diseases coupled with the COVID-19 pandemic is expected to drive the market for active pharmaceutical ingredients. Furthermore, the surging investments in research and
Automotive Data Logger Market: Research Strategies with Share Analysis, Top Key …
Modern car data loggers are more expensive than traditional OBD-I systems. However, data loggers that simply support CAN and LIN channels are less expensive than those that handle all of the major channels (CAN, LIN, FlexRay, and Ethernet). This is also dependent on the amount of analog and digital inputs that data loggers can accommodate. OEMs are always pressuring data logger vendors to reduce device pricing while preserving device quality.

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning